Recent Faculty Publications

Our research, which reflects the wide scope of interests encompassed by our division, frequently appears in leading academic journals.

Matthew Hudson, MD

Hudson MJ, Park SC, Mathers A, Parikh H, Glowicz J, Dar D, Nabili M, LiPuma JJ, Bumford A, Pettengill MA, Sterner MR, Paoline J, Tressler S, Peritz T, Gould J, Hutter SR, Moulton-Meissner H, Perkins KM. (2022) Outbreak of Burkholderia stabilis Infections Associated with Contaminated Nonsterile, Multiuse Ultrasound Gel - 10 States, May-September 2021. MMWR. Morbidity and mortality weekly report (Dec), 71(48): 1517-1521. doi:10.15585/mmwr.mm7148a3
Dale AP, Hudson MJ, Armenta D, Friebus H, Ellingson KD, Davis K, Cullen T, Brady S, Komatsu KK, Stone ND, Uyeki TM, Slifka KJ, Pérez-Vélez CM, Keaton AA. (2022) Clinical outcomes of monoclonal antibody therapy during a COVID-19 outbreak in a skilled nursing facility-Arizona, 2021. Journal of the American Geriatrics Society (Apr), 70(4): 960-967. doi:10.1111/jgs.17705
Bardossy AC, Korhonen L, Schatzman S, Gable P, Herzig C, Brown NE, Beshearse E, Varela K, Sabour S, Lyons AK, Overton R, Hudson M, Hernandez-Romieu AC, Alvarez J, Roman K, Weng M, Soda E, Patel PR, Grate C, Dalrymple LS, Wingard RL, Thornburg NJ, Halpin ASL, Folster JM, Tobin-D'Angelo M, Lea J, Apata I, McDonald LC, Brown AC, Kutty PK, Novosad S. (2021) Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis. Kidney360 (Dec), 2(12): 1917-1927. doi:10.34067/KID.0004372021

Duve RJ, Moga TG, Yang K, Mahl TC, Dove E. (2023) Hepatic Amyloidosis With Multiorgan Involvement. ACG case reports journal (Apr), 10(4): e00999. doi:10.14309/crj.0000000000000999
Yang K, Moga T, Nallapeta NS, Duve R, Miranda CJ, Ismail M, Mahl T. (2022) Severe Cholestatic Drug-Induced Liver Injury With Cephalosporin Use. Cureus (Dec), 14(12): e32262. doi:10.7759/cureus.32262
Miranda CJ, Ali MH, Ayaz M, Soofi Y, Mahl TC. (2022) An Obscure Presence of Gastroduodenal Involvement in a Newly Diagnosed Ileocolonic Crohn's Disease Patient. Case reports in gastrointestinal medicine (Jan), 2022: 2200438. doi:10.1155/2022/2200438

Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, Brown LS. (2024) Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial. JAMA (Apr). doi:10.1001/jama.2024.2452
Ventuneac A, Dickerson SS, Dharia A, George SJ, Talal AH. (2023) Scaling and Sustaining Facilitated Telemedicine to Expand Treatment Access Among Underserved Populations: A Qualitative Study. Telemedicine journal and e-health : the official journal of the American Telemedicine Association (Dec), 29(12): 1862-1869.
Talal AH, Jaanimägi U, Dharia A, Dickerson SS. (2023) Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder. Health expectations : an international journal of public participation in health care and health policy (Dec), 26(6): 2594-2607. doi:10.1111/hex.13854